|
Volumn 35, Issue 7, 2003, Pages 2729-2730
|
Intraoperative anti-thymocyte globulin-fresenius bolus induction therapy in kidney transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIMETABOLITE;
AZATHIOPRINE;
CALCINEURIN INHIBITOR;
CYCLOSPORIN;
CYCLOSPORIN A;
GLOBULIN FRESENIUS THYMOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
POLYCLONAL ANTIBODY;
PREDNISONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
UNCLASSIFIED DRUG;
ADOLESCENT;
ADULT;
AGED;
AMYLOIDOSIS;
BOLUS INJECTION;
CHRONIC GLOMERULONEPHRITIS;
CHRONIC PYELONEPHRITIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HIGH RISK PATIENT;
HUMAN;
IMMUNOGLOBULIN A NEPHROPATHY;
IMMUNOSUPPRESSIVE TREATMENT;
INTERSTITIAL NEPHRITIS;
INTRAOPERATIVE PERIOD;
KIDNEY INFECTION;
KIDNEY POLYCYSTIC DISEASE;
KIDNEY TRANSPLANTATION;
LOW DRUG DOSE;
MALE;
ORGAN DONOR;
PATIENT MONITORING;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
SIDE EFFECT;
SINGLE DRUG DOSE;
|
EID: 0242637240
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2003.09.038 Document Type: Conference Paper |
Times cited : (2)
|
References (12)
|